Evaluation of the Prognostic Factors and Significance of Lymph Node Status in Invasive Ductal Carcinoma of the Body or Tail of the Pancreas

Pancreas

Volumn 39, Issue 1, 2010, Pages

  Fujita, Takeo ^a   Nakagohri, Toshio ^a   Gotohda, Naoto ^a   Takahashi, Shinichiro ^a   Konishi, Masaru ^a   Kojima, Motohiro ^a   Kinoshita, Taira ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Distal pancreatectomy; Lymph node metastasis; Lymph nodes attached to the pancreas; Pancreas cancer; Pancreatic body and tail of carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; NERVE CELL; NERVE PLEXUS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; UNIVARIATE ANALYSIS;

CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 74049117028     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bd5cfa     Document Type: Article

References (19)

1. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223;506-511.
2. Nakao A, Harada A, Nonami T, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84;1090-1092.
3. Sperti C, Pasquali C, Pedrazzoli S. Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg. 1997;185;255-259.
4. Shimada K, Sakamoto Y, Sano T, et al. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006;139;288-295.
5. Shoup M, Conlon KC, Klimstra D, et al. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg. 2003;7;946-952.
6. Japan Pancreas Society. Classification of Pancreatic Carcinoma. 2nd ed. Kanehara, Tokyo; Kanehara; 2003.
7. Japan Pancreas Society. General Rules for the Study of Pancreas Cancer. 5th ed. Kanehara, Tokyo; Kanehara; 2002.
8. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors. New York, NY; Wiley-Liss; 2002.
9. Nordback IH, Hruban RH, Boitnott JK, et al. Carcinoma of the body and tail of the pancreas. Am J Surg. 1992;164;26-31.
10. Matsuno S, Sato T. Surgical treatment for carcinoma of the pancreas. Experience in 272 patients. Am J Surg. 1986;152;499-504.
11. Richards AB, Sosin H. Cancer of the pancreas; the value of radical and palliative surgery. Ann Surg. 1973;177;325-331.
12. Ozaki H, Kinoshita T, Kosuge T, et al. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas. Cancer. 1996;77;2240-2245.
13. Nakao A, Harada A, Nonami T, et al. Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg. 1995;82;399-402.
14. Corsini MM, Miller RC, Haddock MG, et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma; the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008;26;3511-3516.
15. Herman JM, Swartz MJ, Hsu CC, et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas; results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008;26;3503-3510.
16. Ghaneh P, Neoptolemos JP. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial or chemoradiotherapy and chemotherapy for pancreas cancer. Surg Oncol Clin N Am. 2004;13;567-587.
17. Neuhaus P, Riess H, Post S, et al. CONKO-001; Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer. J Clin Oncol. 2008;26. Abstract LBA4504.
18. Kayahara M, Nagakawa T, Kobayashi H, et al. Lymphatic flow in carcinoma of the head of the pancreas. Cancer. 1992;70;2061-2066.
19. O'Morchoe CC. Lymphatic system of the pancreas. Microsc Res Tech. 1997;37;456-477.